PR Newswire, Tuesday, December 02, 1997 at 09:25
MultiPlan, Covering Approximately 20 Million Lives, is Expanding Their Network To Include UroMed as a Continence Care Provider
NEEDHAM, Mass., Dec. 2 /PRNewswire/ -- UroMed Corporation (NASDAQ:URMD),
a company committed to men's and women's health care, today announced that
UroMed will be a Preferred Provider of continence care products within the
MultiPlan, Inc. Network. MultiPlan covers approximately 20 million lives.
UroMed's continuum of covered continence care products includes the
Reliance(R) Urinary Control Insert, the INTROL(R) Bladder Neck Support
Prosthesis and the Impress(TM) Softpatch -- all FDA-cleared for marketing, as
well as the PelvicFlex(TM) Personal Trainer Video. All of these products
offer relief to the millions of American women who suffer from stress urinary
incontinence.
John G. Simon, UroMed's chairman of the board and chief executive officer
commented, "Women deserve access to the superior solutions for incontinence
that we alone offer. We are pleased that MultiPlan has agreed to include
UroMed as part of their network available to their varied client base of
insurance carriers and self-insured organizations, including numerous employer
and labor management plans, as well as governmental agencies."
MultiPlan, Inc., based in New York City, is one of the largest and oldest
PPOs in the United States, serving more than 20 million lives nationwide.
MultiPlan's approach, indicated by its corporate motto "America's managed care
partner," allows it to offer access to healthcare in 49 states. MultiPlan is
a Preferred Provider Organization which offers its members more than
50,000 providers and 23,000 facilities including more than 40 percent of the
acute care hospitals in the nation. UroMed's preferred provider status would
provide MultiPlan enrollees access to UroMed's products.
UroMed, founded in October 1990, is dedicated to establishing itself as a
leader in the development of male and female healthcare products. UroMed has
three primary areas of initial focus: breast cancer, prostate cancer and
incontinence. In the area of incontinence UroMed offers the Reliance Urinary
Control Insert and the INTROL Bladder Neck Support Prosthesis -- both
FDA-cleared for marketing, as well as the PelvicFlex Personal Trainer Video.
In addition, next year UroMed will be offering its FDA-cleared continuum of
care products, the Impress Softpatch, and the BEACON Technology System(TM), a minimally invasive incontinence surgical line. In the area of breast cancer,
UroMed is developing its BreastCheck(TM) breast self examination device
together with its physician-use BreastExam(TM) counterpart device. Both
devices may potentially enhance breast cancer detection. The BreastCheck
technology is an investigational technology and may be available to women in
the U.S. as early as the first part of 1999 if FDA approval is obtained within
that time frame. In the area of prostate cancer UroMed is pleased to offer
the CaverMap(TM) Surgical Aid system. UroMed also continues to dedicate
significant resources to the development and/or acquisition of new options
that fit into UroMed's continuum of care in male and female healthcare.
INTROL Bladder Neck Support Prosthesis and Reliance Urinary Control Insert
are registered trademarks of UroMed Corporation. Impress Softpatch,
PelvicFlex Personal Trainer Video, BEACON Technology System, BreastCheck,
BreastExam and CaverMap Surgical Aid are trademarks of UroMed Corporation.
SOURCE UroMed Corporation
-0- 12/02/97
/CONTACT: Kristen Galfetti, Manager of Investor Relations of UroMed
Corporation, 617-433-0033; or Elizabeth McWilliams, Account Executive of
Ruder-Finn, 212-715-1565, for UroMed/ |
